Severance and Change of Control AgreementSeverance and Change of Control Agreement • May 6th, 2016 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledMay 6th, 2016 Company Industry JurisdictionThis Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 23, 2016 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Rachel Humphrey, Senior Vice President, Chief Medical Officer (“Employee”).